DEREK JANTZ - 03 Mar 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Scientific Officer, Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Derek Jantz
Issuer symbol
DTIL
Transactions as of
03 Mar 2022
Net transactions value
$0
Form type
4
Filing time
07 Mar 2022, 15:26:28 UTC
Previous filing
09 Jun 2021
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Employee Stock Option (Right to Buy) Award $0 +156,271 $0.000000 156,271 03 Mar 2022 Common Stock 156,271 $4.08 Direct F1
transaction DTIL Restricted Stock Units Award $0 +98,401 $0.000000 98,401 03 Mar 2022 Common Stock 98,401 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares on March 3, 2023 and vests in substantially equal installments at the end of each successive three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3 The RSUs shall vest in three substantially equal annual installments on the anniversary of the grant date of such RSUs, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.